Showing results (31-40 of 1,082) with videos related to
Sort By:
Pageof 109
Journal of Parkinson'S Disease|March 1, 2024
Pharmacotherapy for Disease Modification in Early Parkinson's Disease: How Early Should We Be?Philipp Mahlknecht, Werner PoeweNeurologic Clinics|November 30, 2014
Movement disorders in systemic diseasesWerner Poewe, Atbin Djamshidian-TehraniMovement Disorders Clinical Practice|October 27, 2018
Pharmacogenetics of Parkinson's Disease in Clinical PracticeJean-Christophe Corvol, Werner PoeweThe New England Journal of Medicine|September 25, 2009
A double-blind, delayed-start trial of rasagiline in Parkinson's diseaseC Warren Olanow, Olivier Rascol, Robert Hauser, et al.Movement Disorders : Official Journal of the Movement Disorder Society|October 22, 2008
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristicsC Warren Olanow, Robert A Hauser, Joseph Jankovic, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|September 9, 2015
Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson's disease patients with wearing-offMikko Kuoppamäki, Mika Leinonen, Werner PoeweThe Lancet. Neurology|December 20, 2005
The diagnosis of Parkinson's diseaseEduardo Tolosa, Gregor Wenning, Werner PoeweJournal of Neural Transmission (Vienna, Austria : 1996)|July 12, 2025
The role of neuro-imaging in multiple system atrophyFlorian Krismer, Klaus Seppi, Werner PoeweMovement Disorders : Official Journal of the Movement Disorder Society|August 1, 2015
Therapeutic advances in multiple system atrophy and progressive supranuclear palsyWerner Poewe, Philipp Mahlknecht, Florian KrismerParkinson'S Disease|December 15, 2015
Impact of Impulse Control Disorders on Sleep-Wake Regulation in Parkinson's DiseaseAtbin Djamshidian, Werner Poewe, Birgit HöglPageof 109